Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation

Blood

Volumn 124, Issue 8, 2014, Pages 1344-1353

  Myneni, Vamsee D ^a   Hitomi, Kiyotaka ^b   Kaartinen, Mari T ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b NAGOYA UNIVERSITY   (Japan)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRONECTIN; INSULIN; LIPID;

3T3 CELL LINE; ACTIN FILAMENT; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; LIPID STORAGE; LIVER CELL; MODULATION; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ASSEMBLY; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; FACTOR XIII; FIBRONECTINS; HEPATOCYTES; HUMANS; MICE; MICE, KNOCKOUT; TRANSGLUTAMINASES;

EID: 84907353593     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-543223     Document Type: Article

References (72)

1. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357(4):370-379. (Pubitemid 47124137)
2. Malis C, Rasmussen EL, Poulsen P, et al. Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. Obes Res. 2005;13(12):2139-2145.
3. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131(2):242-256. (Pubitemid 47576146)
4. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875-880. (Pubitemid 46028447)
5. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev. May 2002;3(2):85-101. (Pubitemid 34827150)
6. Kaye SM, Pietiläinen KH, Kotronen A, et al. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity (Silver Spring). 2012;20(1):88-94.
7. Nagai N, Hoylaerts MF, Cleuren AC, Van Vlijmen BJ, Lijnen HR. Obesity promotes injury induced femoral artery thrombosis in mice. Thromb Res. 2008;122(4):549-555.
8. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26(5):968-976. (Pubitemid 43732100)
9. Rosito GA, D'Agostino RB, Massaro J, et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost. 2004;91(4):683-689. (Pubitemid 38477447)
10. Naukkarinen J, Surakka I, Pietil äinen KH, et al; ENGAGE Consortium. Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genes. PLoS Genet. 2010;6(6):e1000976.
11. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96(3):988-995.
12. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91(3):931-972.
13. Poon MC, Russell JA, Low S, et al. Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. J Clin Invest. 1989;84(3):787-792. (Pubitemid 19228348)
14. Wölpl A, Lattke H, Board PG, et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Transplantation. 1987;43(1):151-153. (Pubitemid 17002475)
15. Ueki S, Takagi J, Saito Y. Dual functions of transglutaminase in novel cell adhesion. J Cell Sci. 1996;109(Pt 11):2727-2735. (Pubitemid 26388357)
16. Malara A, Gruppi C, Rebuzzini P, et al. Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. Blood. 2011;117(8):2476-2483.
17. Cordell PA, Kile BT, Standeven KF, Josefsson EC, Pease RJ, Grant PJ. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood. 2010;115(13):2674-2681.
18. Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A. Effect of FXIII on monocyte and fibroblast function. Cell Physiol Biochem. 2007;19(1-4):113-120.
19. Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol. 2006;25(3):135-148.
20. Nurminskaya M, Kaartinen MT. Transglutaminases in mineralized tissues. Front Biosci. 2006;11:1591-1606. (Pubitemid 43253379)
21. Nurminskaya M, Magee C, Nurminsky D, Linsenmayer TF. Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization. J Cell Biol. 1998;142(4):1135-1144. (Pubitemid 28402066)
22. Cui C, Wang S, Myneni VD, Hitomi K, Kaartinen MT. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures. Bone. 2014;59:127-138.
23. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991;5(15):3071-3077. (Pubitemid 21892867)
24. Iismaa SE, Mearns BM, Lorand L, Graham RM. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev. 2009;89(3):991-1023.
25. Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Mäenpää PH. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem. 1999;274(3):1729-1735.
26. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol. 2003;4(2):140-156. (Pubitemid 36172696)
27. Nelea V, Nakano Y, Kaartinen MT. Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2. Protein J. 2008;27(4):223-233.
28. Wang S, Cui C, Hitomi K, Kaartinen MT. Detyrosinated Glu-tubulin is a substrate for cellular Factor XIIIA transglutaminase in differentiating osteoblasts. Amino Acids. 2014;46(6):1513-1526.
29. Eckert RL, Kaartinen MT, Nurminskaya M, et al. Transglutaminase regulation of cell function. Physiol Rev. 2014;94(2):383-417.
30. Mosher DF, Schad PE. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest. 1979;64(3):781-787. (Pubitemid 10223757)
31. Singh P, Carraher C, Schwarzbauer JE. Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol. 2010;26:397-419.
32. Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell. 2002;13(10):3546-3559. (Pubitemid 35191374)
33. Sottile J, Hocking DC, Swiatek PJ. Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci. 1998;111(Pt 19):2933-2943. (Pubitemid 28495200)
34. Lee SH, Park HS, Lee JA, et al. Fibronectin gene expression in human adipose tissue and its associations with obesity-related genes and metabolic parameters. Obes Surg. 2013;23(4):554-560.
35. Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell. 1983;35(3 Pt 2):657-666. (Pubitemid 14168370)
36. Wang Y, Zhao L, Smas C, Sul HS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol. 2010;30(14):3480-3492.
37. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem. 2007;282(38):28057-28062. (Pubitemid 47529518)
38. Bentmann A, Kawelke N, Moss D, et al. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function. J Bone Miner Res. 2010;25(4):706-715.
39. Barry EL, Mosher DF. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. J Biol Chem. 1988;263(21):10464-10469.
40. Lauer P, Metzner HJ, Zettlmeissl G, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost. 2002;88(6):967-974. (Pubitemid 36024124)
41. Bennett CN, Ross SE, Longo KA, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002;277(34):30998-31004. (Pubitemid 34970803)
42. Caron NS, Munsie LN, Keillor JW, Truant R. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells. PLoS ONE. 2012;7(8):e44159.
43. Al-Jallad HF, Myneni VD, Piercy-Kotb SA, et al. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. PLoS ONE. 2011;6(1):e15893.
44. Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004;53(11):2748-2756. (Pubitemid 39425899)
45. Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obese. 2005;29(8):1006-1009. (Pubitemid 41076243)
46. Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM. The role of tissue transglutaminase in cell-matrix interactions. Front Biosci. 2006;11:1057-1076. (Pubitemid 43253460)
47. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12(11):722-734.
48. Croissandeau G, Chrétien M, Mbikay M. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem J. 2002;364(Pt 3):739-746. (Pubitemid 34680850)
49. Feng T, Szabo E, Dziak E, Opas M. Cytoskeletal disassembly and cell rounding promotes adipogenesis from ES cells. Stem Cell Rev. 2010;6(1):74-85.
50. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM. RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res. 2005;20(10):1858-1866. (Pubitemid 41361888)
51. Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken). 2010;67(9):545-554.
52. Noguchi M, Hosoda K, Fujikura J, et al. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. J Biol Chem. 2007;282(40):29574-29583. (Pubitemid 350043374)
53. Sit ST, Manser E. Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci. 2011;124(Pt 5):679-683.
54. Corbett SA, Lee L, Wilson CL, Schwarzbauer JE. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem. 1997;272(40):24999-25005. (Pubitemid 27415679)
55. Hoffmann BR, Annis DS, Mosher DF. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA. J Biol Chem. 2011;286(37):32220-32230.
56. Mosher DF. Cross-linking of plasma and cellular fibronectin by plasma transglutaminase. Ann N Y Acad Sci. 1978;312:38-42. (Pubitemid 8385426)
57. Verderio E, Gaudry C, Gross S, Smith C, Downes S, Griffin M. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem. 1999;47(11):1417-1432.
58. Sugimura Y, Hosono M, Wada F, Yoshimura T, Maki M, Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J Biol Chem. 2006;281(26):17699-17706. (Pubitemid 44035568)
59. Asthagiri AR, Reinhart CA, Horwitz AF, Lauffenburger DA. The role of transient ERK2 signals in fibronectin- and insulin-mediated DNA synthesis. J Cell Sci. 2000;113(Pt 24):4499-4510. (Pubitemid 32117910)
60. Pagès G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouysségur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA. 1993;90(18):8319-8323. (Pubitemid 23277659)
61. Bays HE, Gonz ález-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343-368.
62. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783-809. (Pubitemid 28340604)
63. Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol. 2010;323(1):20-34.
64. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol. 2007;2:31-56. (Pubitemid 46448059)
65. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006;7(12):885-896. (Pubitemid 44871415)
66. Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol. 2001;3(3):267-275. (Pubitemid 32201322)
67. Taleb S, Cancello R, Clément K, Lacasa D. Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology. 2006;147(10):4950-4959. (Pubitemid 44402202)
68. Hudak CS, Sul HS. Pref-1, a gatekeeper of adipogenesis. Front Endocrinol (Lausanne). 2013;4:79.
69. Lilla J, Stickens D, Werb Z. Metalloproteases and adipogenesis: a weighty subject. Am J Pathol. 2002;160(5):1551-1554. (Pubitemid 34525633)
70. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100(3):743-754.
71. Mansfield MW, Kohler HP, Ariëns RA, McCormack LJ, Grant PJ. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care. 2000;23(5):703-705. (Pubitemid 30321556)
72. Muszbek L, Bereczky Z, Bagoly Z, Shemirani AH, Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost. 2010;36(1):18-33.